Survival trends of us dialysis patients with heart failure: 1995 to 2005

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 8, 2011, Pages 1982-1989

  Stack, Austin G ^a,b   Mohammed, Amir ^a   Hanley, Alan ^a   Mutwali, Arif ^a   Nguyen, Hoang ^c  

^a LETTERKENNY GENERAL HOSPITAL   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c Lifestat Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONGESTIVE HEART FAILURE; DIALYSIS; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 80051556904     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01130211     Document Type: Article

References (26)

1. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, associations, prognosis and risk factors. Kidney Int 47: 884-890, 1995
2. Stack AG, Bloembergen WE: A Cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001 38: 992-1000, 2001
3. Schreiber BD: Congestive heart failure in patients with chronic kidney disease and on dialysis. Am J Med Science 325: 179-193, 2003
4. Comorbid conditions and correlations with mortality risk among 3,399 incident Hemodialysis patients. Am J Kidney Dis 20: 32-38, 1992
5. U. S Renal Data System: Causes of death. Am J Kidney Dis 34[Suppl 1]: S87-S94, 1999
6. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A: Erythropoietin should be part of congestive heart failure management. Kidney Int Suppl 87: S40-S47, 2003
7. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabrò R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol 41: 1438-1444, 2003
8. Cice G, Di Benedetto A, D'Isa S, D'Andrea A, Marcelli D, Gatti E, Calabrò R: Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: A doubleblind, placebo-controlled trial. J Am Coll Cardiol 56: 1701-1708, 2010
9. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B: Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 64: 1071-1079, 2003
10. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG: Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14: 415-424, 2003
11. US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2009
12. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17: 1518-1521, 2002
13. Sehgal AR, Leon JB, Siminoff LA, Singer ME, Bunosky LM, Cebul RD: Improving the quality of hemodialysis treatment: A community-based randomized controlled trial to overcome patient-specific barriers. JAMA 287: 1961-1967, 2002
14. Sugarman JR, Frederick PR, Frankenfield DL, Owen WF Jr, McClellan WM: Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: Process, outcomes, and implications. Am J Kidney Dis 42: 806-812, 2003
15. Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK: Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis 45: 127-135, 2005
16. McClellan WM, Hodgin E, Pastan S, McAdams L, Soucie M: A randomized evaluation of two health care quality improvement program (HCQIP) interventions to improve the adequacy of hemodialysis care of ESRD patients: Feedback alone versus intensive intervention. J Am Soc Nephrol 15: 754-760, 2004
17. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2002
18. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45[Suppl 3]: S1-153, 2005
19. US Renal Data System: Patient characteristics at the start of ESRD: Data from the HCFA Medical Evidence Form. Am J Kidney Dis 34: S63-S73, 1999
20. Longnecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR: Validation of comorbid conditions on the endstage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11: 520-529, 2000
21. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
22. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE: Prevalence of heart failure and left ventricular dysfunction in the general population: The Rotterdam Study. Eur Heart J 20: 447-455, 1999
23. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD: Confirmation of a heart failure epidemic: Findings from the Resource Utilization among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39: 60-69, 2002
24. Parashar S, Katz R, Smith NL, Arnold AM, Vaccarino V, Wenger NK, Gottdiener JS: Race, gender, and mortality in adults ≥65 years of age with incident heart failure (from the Cardiovascular Health Study). Am J Cardiol 103: 1120-1127, 2009
25. Herzog CA, Solid CA: Long-term survival of US dialysis patients after surgical bypass or percutaneous coronary stent placement in the drug-eluting stent era. J Am Soc Nephrol 19: 11A, 2008
26. Herzog CA, Gilbertson DT: Comparative long-term survival of general Medicare patients with surgical versus percutaneous coronary intervention in the era of drug-eluting stents and the impact of chronic kidney disease. Circulation 118[Suppl 2]: S741A, 2008